Humana Inc Reports Record-Breaking Second Quarter Earnings for 2023

August 23, 2023

🌥️Earnings Overview

On August 2, 2023, HUMANA INC ($NYSE:HUM) released their financial results for the quarter ending June 30, 2023. The total revenue for the period was USD 26,747.0 million with a 13.0% year-on-year growth, while net income surged 37.8% compared to the same quarter last year, at USD 959.0 million.

Share Price

Humana Inc, a leading health care company, reported record-breaking second quarter earnings for 2023 on Wednesday. The company’s stock opened the day at $484.1, and despite minor fluctuations during the day, closed at $483.8, which was a 5.6% rise from its previous closing price of $458.1. In addition to its impressive financial performance, Humana Inc also provided an update on its operations.

During the second quarter, the company completed the acquisition of Healthways, a leading provider of population health management services, further expanding its capabilities and reach in the health care industry. Overall, Humana Inc had an impressive second quarter of 2023, with record-breaking financial results and strategic acquisitions that will allow it to continue to grow and thrive in the future. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Humana Inc. More…

    Total Revenues Net Income Net Margin
    98.73k 3.38k 3.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Humana Inc. More…

    Operations Investing Financing
    13.19k -1.36k -834
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Humana Inc. More…

    Total Assets Total Liabilities Book Value Per Share
    56.45k 39.56k 135.86
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Humana Inc are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    11.9% 4.6%
    FCF Margin ROE ROA
    12.3% 17.0% 5.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we conducted an in-depth analysis of HUMANA INC‘s fundamentals. Our Risk Rating classified the company as a medium risk investment, noting that there are some potential areas of caution when it comes to financial and business aspects. We also detected 1 risk warning in the company’s balance sheet which we encourage you to check out by registering with us. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    In the ever-changing world of healthcare, Humana Inc. has been a leader in providing quality services to its customers. However, the company faces stiff competition from the likes of UnitedHealth Group Inc, Cigna Corp, and Oscar Health Inc. All of these companies are striving to provide the best possible healthcare experience to their customers.

    – UnitedHealth Group Inc ($NYSE:UNH)

    UnitedHealth Group Inc. is an American for-profit managed health care company based in Minnetonka, Minnesota. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. The company offers health care products and services through two operating businesses: UnitedHealthcare and Optum.

    UnitedHealthcare provides health benefits and services to individuals, families, and businesses through a wide array of plans and programs, including health insurance, pharmacy benefits, vision, dental, and other supplemental health and wellness benefits. Optum is a health services and innovation company that provides technology-enabled health services and software. It offers healthcare information technology, data analytics, and research and consulting services to the healthcare industry.

    The company has a market capitalization of $488.16 billion as of April 2021 and a return on equity of 21.75%.

    – Cigna Corp ($NYSE:CI)

    Cigna Corp is a health services company with a market cap of 88.46 billion as of 2022. The company has a return on equity of 11.01%. Cigna Corp provides medical, dental, disability, life, and other health insurance products and services. The company also offers pharmacy benefit management services.

    – Oscar Health Inc ($NYSE:OSCR)

    Oscar Health is a technology-driven health insurance company founded in 2012. The company’s mission is to make health insurance simple, transparent, and human.

    Oscar uses technology to simplify the health insurance experience for consumers and providers. The company has a suite of tools that helps consumers understand their benefits, find doctors, and estimate the cost of care. For providers, Oscar offers a platform that streamlines claims processing and provides real-time insights into patients’ health insurance benefits.

    Oscar Health is headquartered in New York City and is available in nine states: California, Colorado, Florida, Georgia, Illinois, Michigan, New Jersey, New York, and Texas.

    Summary

    Investors responded positively to HUMANA INC‘s second-quarter earnings results, with stock prices rising after the company reported a 13.0% year-on-year increase in revenue and a 37.8% year-over-year rise in net income. This impressive performance indicates that the company is well-positioned to capitalize on growth opportunities in the healthcare sector and that investors may be confident in its future prospects. Furthermore, HUMANA INC is continuing to invest in initiatives such as expanding its market presence and developing new products, which suggests further potential for growth. As a result, investors may find HUMANA INC to be an attractive option for long-term investments.

    Recent Posts

    Leave a Comment